Hypermarcas (OTCMKTS:HYPMY) Sees Large Growth in Short Interest

Hypermarcas (OTCMKTS:HYPMY) saw a significant growth in short interest in January. As of January 15th, there was short interest totaling 544 shares, a growth of 3,300.0% from the December 31st total of 16 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,007 shares, the short-interest ratio is currently 0.1 days. Based on an average daily trading volume, of 4,007 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.

Hypermarcas Price Performance

OTCMKTS HYPMY traded up $0.01 during trading on Tuesday, hitting $4.95. 51,051 shares of the stock traded hands, compared to its average volume of 2,477. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. Hypermarcas has a 12-month low of $3.04 and a 12-month high of $5.18. The firm has a 50-day simple moving average of $4.51 and a 200-day simple moving average of $4.44. The company has a market capitalization of $3.14 billion, a P/E ratio of 21.52 and a beta of 0.72.

Hypermarcas (OTCMKTS:HYPMY) last posted its earnings results on Wednesday, November 12th. The company reported $0.13 EPS for the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.The firm had revenue of $408.83 million during the quarter.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.